Repaglinide
CAS 135062-02-1
Visão geral
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus
A Anant Labs fabrica e fornece impurezas de Repaglinide de alta qualidade para o mercado global. Nossas impurezas EP de Repaglinide são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Dados Técnicos
CAS135062-02-1
Fórmula Mol.C27H36N2O4
Peso Mol.452.595 g/mol
IUPAC2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
SMILESCCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
InChIInChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1
Chave InChIFAEKWTJYAYMJKF-QHCPKHFHSA-N
Note: We are upgrading our system, Cat No will change.
Sinônimos
Repaglinide135062-02-1PrandinGlucoNormRepaglinidaAG-EE 623 ZWRepaglinidumAG-EE 388 ZWAGEE-623ZWAG-EE-623ZW
